214 related articles for article (PubMed ID: 17967857)
1. Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.
Cazorla SI; Becker PD; Frank FM; Ebensen T; Sartori MJ; Corral RS; Malchiodi EL; Guzmán CA
Infect Immun; 2008 Jan; 76(1):324-33. PubMed ID: 17967857
[TBL] [Abstract][Full Text] [Related]
2. Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against
Cerny N; Bivona AE; Sanchez Alberti A; Trinitario SN; Morales C; Cardoso Landaburu A; Cazorla SI; Malchiodi EL
Front Immunol; 2020; 11():565142. PubMed ID: 33162979
[TBL] [Abstract][Full Text] [Related]
3. Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.
Cerny N; Sánchez Alberti A; Bivona AE; De Marzi MC; Frank FM; Cazorla SI; Malchiodi EL
Hum Vaccin Immunother; 2016; 12(2):438-50. PubMed ID: 26312947
[TBL] [Abstract][Full Text] [Related]
4. Prime-boost immunization with cruzipain co-administered with MALP-2 triggers a protective immune response able to decrease parasite burden and tissue injury in an experimental Trypanosoma cruzi infection model.
Cazorla SI; Frank FM; Becker PD; Corral RS; Guzmán CA; Malchiodi EL
Vaccine; 2008 Apr; 26(16):1999-2009. PubMed ID: 18342408
[TBL] [Abstract][Full Text] [Related]
5. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.
Schnapp AR; Eickhoff CS; Sizemore D; Curtiss R; Hoft DF
Infect Immun; 2002 Sep; 70(9):5065-74. PubMed ID: 12183554
[TBL] [Abstract][Full Text] [Related]
6. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.
Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF
Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727
[TBL] [Abstract][Full Text] [Related]
7. Oral multicomponent DNA vaccine delivered by attenuated Salmonella elicited immunoprotection against American trypanosomiasis.
Cazorla SI; Matos MN; Cerny N; Ramirez C; Alberti AS; Bivona AE; Morales C; Guzmán CA; Malchiodi EL
J Infect Dis; 2015 Mar; 211(5):698-707. PubMed ID: 25160983
[TBL] [Abstract][Full Text] [Related]
8. Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes.
Frank FM; Petray PB; Cazorla SI; Muñoz MC; Corral RS; Malchiodi EL
Vaccine; 2003 Dec; 22(1):77-86. PubMed ID: 14604574
[TBL] [Abstract][Full Text] [Related]
9. Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.
de Alencar BC; Persechini PM; Haolla FA; de Oliveira G; Silverio JC; Lannes-Vieira J; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
Infect Immun; 2009 Oct; 77(10):4383-95. PubMed ID: 19651871
[TBL] [Abstract][Full Text] [Related]
10. A prime-boost immunization with Tc52 N-terminal domain DNA and the recombinant protein expressed in Pichia pastoris protects against Trypanosoma cruzi infection.
Matos MN; Sánchez Alberti A; Morales C; Cazorla SI; Malchiodi EL
Vaccine; 2016 Jun; 34(28):3243-51. PubMed ID: 27177947
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.
Gupta S; Garg NJ
PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586
[TBL] [Abstract][Full Text] [Related]
12. Heterologous Chimeric Construct Comprising a Modified Bacterial Superantigen and a Cruzipain Domain Confers Protection Against
Antonoglou MB; Sánchez Alberti A; Redolfi DM; Bivona AE; Fernández Lynch MJ; Noli Truant S; Sarratea MB; Iannantuono López LV; Malchiodi EL; Fernández MM
Front Immunol; 2020; 11():1279. PubMed ID: 32695105
[TBL] [Abstract][Full Text] [Related]
13. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
[TBL] [
